Literature DB >> 6934538

Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.

L W DeBoer, H W Strauss, R A Kloner, R E Rude, R F Davis, P R Maroko, E Braunwald.   

Abstract

Investigation of the efficacy of pharmacologic agents affecting myocardial infarct size after coronary artery occlusion is complicated by the variability of collateral flow among experimental animals which results in variability of infarct size. To overcome this difficulty, we developed an autoradiographic method to delineate the ischemic area at risk of necrosis after coronary artery occlusion and we invetigated the potential protective effect of a calcium antagonist verapamil. The left anterior descending coronary arteries of 25 barbiturate-anesthetized dogs were occluded. Thirty minutes later, highly radioactive human albumin microspheres labeled with 99mTc were injected into the left atrium. One hour after coronary artery occlusion, dogs were randomized to control or treated groups; the latter received a 0.2 mg/kg loading dose and 0.6 mg/kg per hr maintenance dose of verapamil intravenously. Eight hours after coronary artery occlusion, the dogs were killed, the hearts were excised, and the left ventricle was sectioned parallel to the atrioventricular groove; infarct size was determined planimetrically after incubation in triphenyl tetrazolium chloride. The slices were then exposed to high-speed x-ray film with image-enhancing screens. The percentage of left ventricle that was ischemic, as determined by planimetry of autoradiographs, was similar in treated and control animals (36.6 +/- 2.0% compared to 37.3 +/- 2.8%, respectively). Of the ischemic area, 92.0 +/- 4.3% was infarcted in control animals and 70.5 +/- 5.1% was infarcted in treated animals (P < 0.01). Thus, this autoradiographic method using 99mTc-labeled human albumin microspheres is useful in delineating the area of ischemia after coronary artery occlusion and in evaluating the efficacy of pharmacologic agents designed to protect ischemic myocardium. Verapamil, administered 1 hr after coronary artery occlusion, is effective in limiting infarct size.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6934538      PMCID: PMC350225          DOI: 10.1073/pnas.77.10.6119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Reduction of the size of acute, experimental myocardial infarction by Verapamil.

Authors:  W Wende; W Bleifeld; J Meyer; H W Stühlen
Journal:  Basic Res Cardiol       Date:  1975 Mar-Apr       Impact factor: 17.165

2.  Myocardial perfusion imaging with radioactive-labeled particles injected directly into the coronary circulation of patients with coronary artery disease.

Authors:  W L Ashburn; E Braunwald; A L Simon; K L Peterson; J H Gault
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

3.  Feasibility and hazards of the intracoronary injection of radioactive serum albumin macroaggregates for external myocardial perfusion imaging.

Authors:  H R Schelbert; W L Ashburn; J W Covell; A L Simon; E Braunwald; J Ross
Journal:  Invest Radiol       Date:  1971 Nov-Dec       Impact factor: 6.016

4.  The direct diagnosis of human myocardial ischemia using 131I-MAA via the selective coronary catheter. Preliminary report.

Authors:  M Endo; T Yamazaki; S Konno; H Hiratsuka; T Akimoto; T Tanaka; S Sakakibara
Journal:  Am Heart J       Date:  1970-10       Impact factor: 4.749

5.  Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs.

Authors:  J T Lie; P C Pairolero; K E Holley; J L Titus
Journal:  J Thorac Cardiovasc Surg       Date:  1975-04       Impact factor: 5.209

6.  Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.

Authors:  K A Reimer; J E Lowe; R B Jennings
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

7.  Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone.

Authors:  W G Nayler; E Fassold; C Yepez
Journal:  Cardiovasc Res       Date:  1978-03       Impact factor: 10.787

8.  Effects of verapamil on infarct size following experimental coronary occlusion.

Authors:  H J Smith; B N Singh; H D Nisbet; R M Norris
Journal:  Cardiovasc Res       Date:  1975-07       Impact factor: 10.787

9.  The effect of verapamil on experimental myocardial ischaemia with a particular reference to regional myocardial blood flow and metabolism.

Authors:  H J Smith; B N Singh; R M Norris; H D Nisbet; M B John; P J Hurley
Journal:  Aust N Z J Med       Date:  1977-04

10.  Myocardial perfusion scintigraphy after intracoronary injection of 99m Tc-labeled human albumin microspheres. Toxicity and efficacy for detecting myocardial infarction in dogs; preliminary results in man.

Authors:  D A Weller; R J Adolph; H N Wellman; R G Carroll; O Kim
Journal:  Circulation       Date:  1972-11       Impact factor: 29.690

View more
  15 in total

1.  Mitochondria, the calcium uniporter, and reperfusion-induced ventricular fibrillation.

Authors:  H Clements-Jewery
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

2.  Effects on infarct size of reperfusion and pretreatment with beta-blockade and calcium antagonists.

Authors:  S Torr; A J Drake-Holland; M Main; J Hynd; K Isted; M I Noble
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

Review 3.  Calcium antagonists in the post-myocardial infarction setting.

Authors:  B D Bertolet
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

4.  A comparison of two methods for estimating the area at risk in experimental myocardial infarction.

Authors:  J Vanhaecke; R Xhonneux; W Flameng
Journal:  Basic Res Cardiol       Date:  1986 May-Jun       Impact factor: 17.165

5.  The Danish studies on verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

6.  Ineffectiveness of methylprednisolone to reduce infarct size in experimental coronary occlusion.

Authors:  K Genth; M Hofmann; W Schaper
Journal:  Basic Res Cardiol       Date:  1982 Mar-Apr       Impact factor: 17.165

7.  Three-dimensional distribution of collateral blood flow within the anatomic area at risk after circumflex coronary artery occlusion in dogs.

Authors:  K A Reimer; J B Long; C E Murry; R B Jennings
Journal:  Basic Res Cardiol       Date:  1987 Sep-Oct       Impact factor: 17.165

8.  Limitation of myocardial necrosis with verapamil during sustained coronary occlusion in the closed-chest dog.

Authors:  J G Kingma; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

9.  Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs.

Authors:  S Yoshida; J M Downey; F R Friedman; D E Chambers; D J Hearse; D M Yellon
Journal:  Basic Res Cardiol       Date:  1985 Jan-Feb       Impact factor: 17.165

10.  A modified regionally ischemic porcine heart preparation with eligible residual blood flows.

Authors:  H H Klein; K Nebendahl; S Lindert; J Schrader; H Kreuzer
Journal:  Basic Res Cardiol       Date:  1986 Jul-Aug       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.